👤 Meet Felix Prehn: I'm your host, Felix Prehn. My journey took me from being a novice investor to an investment banker, a corporate lawyer, and an entrepreneur. Investing was my key to early retirement at 40. My goal? To empower YOU to navigate the financial market with ease and transparency, free from the conventional financial system's noise. Let's embark on this journey to financial freedom together!
⚖️This is from my lovely lawyers: The content in this video is for informational and educational purposes only. It does not constitute and should not be construed as financial or investment advice or an offer to purchase or sell securities. The content is not personalized or tailored to a specific person or group of persons, nor to their personal investment or financial needs. You should consult a financial adviser or other investment professional authorized to provide investment advice. Investing comes with risks, including the risk of loss. Presentations of trades made by Felix Prehn or Goat Academy Ltd or its personnel are not a guarantee that any investment decision made by a student will be successful. Past performance is not a guarantee of future performance.
Some of the accounts we highlight from time to time are our top performing accounts and the results shown are not typical. Trades shown may be from simulated trading or live trading accounts. *CFTC RULE 4.41 – HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN
Timestamps: 00:00 Intro 00:17 Overview of Stoke Therapeutics ($STOK) and Their Mission in Biotech 01:00 Why Relying on Stock Tips Alone Won’t Build Long-Term Wealth 01:25 How Stoke’s RNA Medicines Work to Treat Rare Genetic Diseases 02:36 A Look at Other Promising Treatments in Stoke’s Drug Pipeline 02:55 Strategic Collaborations with Biogen and Acadia Pharmaceuticals 03:13 Analyst Ratings and Price Targets: Wall Street’s View on $STOK 03:55 Chart Analysis Breakdown: Why $STOK’s Breakout Pattern Looks Strong 04:45 Why You Need a Clear System for Risk Management and Position Sizing 05:19 How to Lock In Gains and Reduce Risk Through Smart Stop-Loss Moves 05:53 Why the Current Price Action in $STOK Still Looks Attractive to Traders 06:00 Outro
